Loading…

Baseline PET Metabolic Tumor Volume Predicts Outcome in Advanced Follicular Lymphoma Patients Who Received First-Line Immunochemotherapy but Not Those Treated with Lenalidomide-Rituximab in the Phase III Relevance Study

Saved in:
Bibliographic Details
Published in:Blood 2022-11, Vol.140 (Supplement 1), p.6474-6476
Main Authors: Cottereau, Anne Ségolène, Rebaud, Louis, Trotman, Judith, Feugier, Pierre, Nastoupil, Loretta J., Bachy, Emmanuel, Flinn, Ian W., Haioun, Corinne, Ysebaert, Loic, Bartlett, Nancy L., Tilly, Hervé, Casasnovas, René-Olivier, Ricci, Romain, Portugues, Cedric, Buvat, Irène, Meignan, Michel, Morschhauser, Franck
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-159207